In light of proposed and actual changes in Federal and State policy that have the potential to affect the 340B program, we conducted a rapid response study, exploring the impact to facilities that serve people living with or at risk for HIV. As a companion to the Navigating 340B Toolkit, this Explainer takes a closer look at the answers to these three questions: 1. How does 340B work? 2. What is the relationship between 340B and HIV services? 3. What are the current factors impacting 340B revenue for HIV clinical and service organizations?
In February 2024, Senate Bill 339 was signed into law to help realize the goal of widespread access to HIV pre- and post-exposure prophylaxis (PrEP and PEP) in California pharmacies. This fact sheet explains key changes under Senate Bill 339 that may reduce previously-identified barriers to pharmacist delivery of PrEP/PEP.
The COVID-19 pandemic has renewed concerns about social and structural factors related to health disparities, including those related to HIV. The Lens tool is a partial response to an urgent need to understand whether elevated risk of COVID-19 disease and mortality among persons living with HIV (PLWH) results from related risk behaviors, a higher burden […]
This fact sheet provides an overview of recently released state and federal guidance implementing the U.S. Preventive Services Task Force (USPSTF) Grade A recommendation for pre-exposure prophylaxis (PrEP) and Senate Bill (SB) 159. The fact sheet also outlines the complaint process if a health plan is not in compliance with the new requirements.
This policy brief is intended to help health care providers and patients better understand how the U.S. Preventive Services Task Force (USPSTF) Grade A recommendation for pre-exposure prophylaxis (PrEP) and Senate Bill (SB) 159 impact PrEP access in California. The policy brief also outlines the complaint process if a health plan is not in compliance with the […]
Contingency management (CM) is a behavioral intervention that promotes healthy behavior using positive reinforcement in the form of rewards. Originally developed to treat substance use disorders, CM was adopted by public health practitioners and policymakers to help bring about a variety of positive health outcomes, including employment seeking behaviors, starting and continuing to take prescribed […]
Given the low uptake of daily oral PrEP, exploration of safe alternative agents (e.g. medications) and alternative modalities to deliver PrEP (e.g. alternative dosing, injectables, topical agents, and long-acting treatment) are integral to address PrEP disparities moving forward. The purpose of this brief is to provide an overview of existing and future PrEP agents and […]
Access to health care is a growing concern for immigrants living in the U.S. This brief report describes how immigrants may be deterred from seeking health care services, and how this may affect the continuity of HIV care and prevention. The report also features recommendations for HIV care providers who serve immigrant communities.
Covered California is the state’s health insurance marketplace where qualified residents of California can purchase affordable health insurance. Given recent events in Washington D.C., you may have questions about how actions taken by the federal government will impact your health coverage. This guide is designed specifically to help people living with HIV and hepatitis C […]
